Study on the use of Panax NotoGinseng LUOTAI in ischemic stroke in Senegal

Observational study on the use of Panax NotoGinseng LUOTAI in ischemic cerebrovascular accidents in Senegal

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

PACTR

Registry ID

PACTR201907715482365

Enrollment

152

Registered

2019-07-12

Start date

2019-01-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Circulatory System Cardiology

Interventions

Controle

oral treatment with Luotai

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Ischemic stroke less than 7 days

Exclusion criteria

Exclusion criteria: • Age inf 40 YO or sup 70YO • Stroke in the 3 last year • Refuse study • No possibility oral médication • Brain trauma

Design outcomes

Primary

Measure	Time frame
Recovery of NIHSS score	—

Secondary

Measure	Time frame
Recovery of Barthel score	—

Countries

Senegal

Contacts

Public ContactSerigne Mor Beye

Cardiologist Gaston Berger University

serigne-mor.beye@ugb.edu.sn+221776776655

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026